Navigation Links
Reminder: Transgenomic to Hold First Quarter Financial Results Conference Call Today
Date:5/12/2011

OMAHA, Neb., May 12, 2011 /PRNewswire/ -- Transgenomic, Inc. (OTC/BB: TBIO) today announced the following Webcast:What:

Transgenomic, Inc. First Quarter 2011 Financial Results and Business Update Conference CallWhen:

Thursday, May 12, 2011 @ 5:00 p.m. EasternWhere:

http://www.transgenomic.com/events.asp?id=6How:

Live over the Internet -- Simply log on to the web at the address above.Contact:

Investor Relations, 402-452-5400 To access the call via telephone, call 800-895-0198 from the U.S. or Canada or 785-424-1053 for international participants and enter conference ID TRANS.  A telephone replay will be available from 6:00 p.m. Eastern Time May 12, 2011 through 11:59 p.m. Eastern Time on May 26, 2011 by dialing 800-374-0328 (domestic) or 402-220-0663 (international).

About Transgenomic, Inc.Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomic analyses.  Transgenomic, Inc. is comprised of 3 different divisions.  Transgenomic Molecular Lab specializes in molecular diagnostics for cardiology, neurology, mitochondrial disorders, oncology, hematology, molecular pathology and other inherited diseases.  Transgenomic Pharmacogenomic Services is a contract research service offering translational research and clinical trial services to pharmaceutical companies in support of pre-clinical and phase I, II and III clinical trials.  Transgenomic's Diagnostic Tools Business product offerings include systems for the automation of sample processing and analysis for Cytogenetic and Molecular Diagnostic testing.  Transgenomic's WAVE® Systems and associated consumables are specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification.  SURVEYOR® Scan Mutation Detection kits provide reagents and protocols for high sensitivity detection of mutations in key cancer pathway genes. HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared with manual methods for cytogenetic karyotyping and FISH analyses.  Transgenomic believes there is a significant opportunity to continue growing the demand for its molecular-based testing across all business lines by leveraging core technologies, experience and expertise in biomarker analysis. In addition, the company continues to seek out and evaluate new technologies and new intellectual property to extend its offerings in molecular diagnostics and pharmacogenomic services.


'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reminder: ADVENTRX Presents Today at the Lippert/Heilshorn Life Sciences & MedTech Virtual Conference
2. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
3. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
4. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
5. Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute
6. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
7. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
8. Transgenomic, Inc. Executes License Option agreement for Parkinsons Disease Diagnostic Markers with Gene Solutions, LLC
9. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
10. Transgenomic Reports Fourth Quarter Financial Results
11. Transgenomic to Present at the Noble Financial Sixth Annual Equity Conference - ONTRACK 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017 Now in its seventh ... that are most successful at developing and commercialising innovation. ... The Index ... same molecule to two different companies in early phase, which ... systematic, objective analysis of each company,s performance between 2011 and 2016, the ...
(Date:2/27/2017)... -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today ... as President and Chief Executive Officer (CEO) and member of ... succeeds Richard Love , interim President and CEO who ... Dr. Craig has over 20 years of experience in hematology, ... Europe . "On behalf of CTI ...
(Date:2/27/2017)... , Feb 27, 2017 The ... by NATO for use at the security level RESTRICTED. The ... the NATO organization for the communication of classified information. ... Sectra and ... with an eavesdrop-secure smartphone solution. Sectra Tiger/R is developed by ...
Breaking Medicine Technology:
(Date:2/27/2017)... , ... February 27, 2017 , ... Robert E. Burke, ... medical group. But his impoverished upbringing and life experiences could have led him down ... Physician: Insightful and Inspirational Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares a ...
(Date:2/27/2017)... TN (PRWEB) , ... February 27, 2017 , ... The ... Clayton went to work for a company involved in the underground testing of nuclear ... In “Dying for Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... an overview on laser diffraction analysis as a tool to characterize particle size ... and potential to obtain improved results and novel scientific findings. It describes methods ...
(Date:2/27/2017)... TX (PRWEB) , ... February 27, 2017 , ... ... 75,000 customer threshold mark last week. In addition, Discount Power's RCE (Residential Customer ... Energy LLC in March 2014. The company had 800 customers and 2,250 RCEs ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair ... to announce an upgrade to the company's Yelp listing. Bay Area residents struggling ... as diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as ...
Breaking Medicine News(10 mins):